Trials / Completed
CompletedNCT00326066
A Study of the iStent in Combo With Cataract Surgery in Newly Diagnosed Open Angle Glaucoma or OH Patients.
A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Newly Diagnosed Open Angle Glaucoma and Subjects Diagnosed With Ocular Hypertension
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- Glaukos Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of the iStent trabecular micro-bypass stent in reducing intraocular pressure (IOP) in subjects with newly diagnosed open-angle glaucoma and subjects diagnosed with Ocular hypertension.
Detailed description
The study will compare the reduction in IOP of those subjects implanted with two Glaukos micro-stents with the reduction in IOP for patients receiving only primary medical therapy (Xalatan - Latanoprost) or cataract surgery alone. Both groups will undergo routine cataract surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Glaucoma Surgery | Comparing the effect in reducing IOP with two Trabecular Bypass Microstents Versus none in patients undergoing cataract surgery, with early open angle glaucoma or ocular hypertension. |
| PROCEDURE | cataract surgery only | Subjects will undergo routine cataract surgery only (no stent implant). |
Timeline
- Start date
- 2005-02-01
- Primary completion
- 2013-05-01
- Completion
- 2013-05-01
- First posted
- 2006-05-16
- Last updated
- 2018-03-09
Locations
9 sites across 5 countries: Austria, Germany, Netherlands, Spain, Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT00326066. Inclusion in this directory is not an endorsement.